Crossref
Baloxavir marboxil versus oseltamivir phosphate: Efficacy, safety, and economics in patients with influenza
Int. Journal of Clinical Pharmacology and Therapeutics · 25.09.2026
DOI: 10.5414/cp204995 ↗Kurz gefasst
Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 25.09.2026. Verfasst von Yongli Gu und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gu, Y., & Jiang, D. (2026). Baloxavir marboxil versus oseltamivir phosphate: Efficacy, safety, and economics in patients with influenza. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204995
Vancouver
Gu Y, Jiang D. Baloxavir marboxil versus oseltamivir phosphate: Efficacy, safety, and economics in patients with influenza. Int. Journal of Clinical Pharmacology and Therapeutics. 2026. doi:10.5414/cp204995
BibTeX
@article{Gu2026,
author = {Gu, Yongli and Jiang, Daoli},
title = {Baloxavir marboxil versus oseltamivir phosphate: Efficacy, safety, and economics in patients with influenza},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
doi = {10.5414/cp204995}
}
EUVIMED